Shop and Compare Conferences

Find out which ones are the best for you and your team to attend with our proprietary standardized scoring system

Go to Lodescore

Brand Tracking & Sales Prospecting

Profile companies, people, and topics with data on presentations, posters, sponsors and exhibitors

Go to Lodescore Analytics

Custom Analysis and Reports

Access live dashboards for competitive insights, budget planning, and ROI measurements

See more

Did you know?

Each year in the United States there are an estimated 1.8 million conventions, conferences, trade shows, and exhibition meetings. In 2015, these events are estimated to attract 247 million participants with an estimated direct spending of $298 billion. When combined with other indirect effects, the conference industry contributes $393 billion annually to US GDP; estimates put this figure at over $1 trillion globally.

With all of the individual and company activities that happen at conferences, they are a rich data resource that can be used for business intelligence and pro-actively monitoring movements within a sector – from scientific innovation, to product launches, to new partnerships/relationships, to trending topics and new perspectives from thought leaders and domain experts. Private equity firms, investment banks, business development professionals, consulting groups, and academic institutions attend conferences to gather information to influence decisions tied to stock and portfolio investments, mergers and acquisitions, identification of new customers, and the development of new products and services.

Recent Posts

Lodescore® Update: Trump and the Changing Healthcare Landscape

In the weeks since the election of Donald Trump, speculation abounds on the future of health care and related industries.  No doubt, the new political landscape will be a key theme at the January J.P. Morgan Annual Healthcare Conference in San Diego. To what extent will the merger and acquisition trend continue? How will the […]

Continue reading

Lodescore® Update: Last Chance for the Cures Act?

Will real world data and patient-centered processes become core to submissions to FDA? The lame-duck Congress that began this week may be the last chance for the 21st Century Cures Act to pass. It highlights the ubiquity of technology (Thank you HITECH!) combining it with partnering with patients and the application of real world data […]

Continue reading

Lodescore® Update: Stats Don’t Lie

We should be petrified. Zika is an imminent threat and rapidly spreading. Is this another ebola situation that could quickly escalate? The CDC just announced the first US-based travel advisory for an infectious disease. Yet, there’s limited funding for research and innovation. Could Cuban scientists help find the answer? Explosive Spread and Devastating Birth Defects […]

Continue reading